US Stock MarketDetailed Quotes

URGN UroGen Pharma Ltd

Watchlist
  • 11.200
  • -0.250-2.18%
Close Mar 28 16:00 ET
  • 11.200
  • 0.0000.00%
Post 20:01 ET
516.26MMarket Cap-3.78P/E (TTM)

UroGen Pharma Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
9.29%90.4M
4.40%24.57M
20.87%25.2M
3.35%21.85M
9.24%18.78M
28.52%82.71M
30.06%23.53M
29.54%20.85M
27.31%21.14M
26.75%17.19M
Operating revenue
9.29%90.4M
4.40%24.57M
20.87%25.2M
3.35%21.85M
9.24%18.78M
28.52%82.71M
30.06%23.53M
29.54%20.85M
27.31%21.14M
26.75%17.19M
Cost of revenue
-5.13%8.88M
8.09%2.47M
3.63%2.45M
-8.76%2.23M
-23.71%1.73M
22.30%9.36M
1.02%2.29M
17.18%2.37M
32.34%2.44M
48.52%2.27M
Gross profit
11.13%81.52M
4.00%22.09M
23.08%22.75M
4.94%19.62M
14.24%17.05M
29.36%73.35M
34.21%21.24M
31.31%18.49M
26.68%18.7M
23.99%14.93M
Operating expense
28.38%178.3M
38.77%49.75M
25.98%40.3M
33.39%45.46M
15.74%42.79M
2.32%138.89M
-0.71%35.85M
-0.56%31.99M
1.81%34.08M
8.75%36.97M
Selling and administrative expenses
29.89%121.15M
41.98%34.86M
33.03%28.94M
33.62%30.06M
11.54%27.3M
12.60%93.27M
13.48%24.55M
14.07%21.76M
7.97%22.49M
14.90%24.47M
Research and development costs
25.28%57.15M
31.78%14.89M
11.00%11.36M
32.96%15.4M
23.97%15.49M
-13.78%45.61M
-21.93%11.3M
-21.87%10.23M
-8.35%11.58M
-1.56%12.5M
Operating profit
-47.68%-96.78M
-89.32%-27.66M
-29.96%-17.55M
-67.98%-25.84M
-16.76%-25.74M
17.09%-65.54M
27.97%-14.61M
25.36%-13.5M
17.81%-15.38M
-0.40%-22.05M
Net non-operating interest income expense
70.02%-3.62M
62.24%-1.08M
101.21%36K
47.71%-1.74M
77.68%-649K
-60.99%-12.07M
-3.85%-2.86M
-32.27%-2.98M
-57.56%-3.33M
-938.57%-2.91M
Non-operating interest income
237.03%8.9M
287.33%2.81M
230.18%2.76M
295.86%1.72M
178.76%1.8M
181.56%2.64M
54.80%726K
89.34%835K
239.84%435K
32,150.00%645K
Non-operating interest expense
-14.91%12.52M
8.53%3.89M
-28.68%2.72M
-7.98%3.46M
-31.13%2.45M
74.39%14.72M
11.26%3.59M
41.61%3.82M
67.98%3.76M
1,159.93%3.55M
Other net income (expense)
-14.13%-23.64M
-30.51%-6.13M
-12.30%-6.07M
-7.69%-5.79M
-11.53%-5.84M
3.60%-20.71M
8.77%-4.69M
-13.09%-5.41M
7.87%-5.37M
10.14%-5.24M
Gain on sale of security
-8.63%-23.41M
-10.14%-6.06M
-7.96%-5.92M
-8.03%-5.77M
-8.35%-5.66M
0.03%-21.55M
-8.34%-5.51M
-13.70%-5.48M
8.38%-5.34M
10.33%-5.22M
Other non- operating income (expenses)
-127.33%-229K
-107.64%-62K
-322.54%-158K
53.33%-14K
-1,120.00%-183K
1,063.89%838K
1,388.89%812K
91.89%71K
---30K
-275.00%-15K
Income before tax
-26.16%-124.04M
-57.31%-34.86M
-7.74%-23.58M
-38.55%-33.37M
-6.76%-32.23M
8.98%-98.32M
21.36%-22.16M
12.87%-21.89M
9.67%-24.08M
-7.57%-30.19M
Income tax
-27.76%2.83M
-31.27%2.65M
1,111.11%91K
-29.63%38K
157.14%54K
123.36%3.92M
459.36%3.85M
-101.27%-9K
68.75%54K
-93.54%21K
Net income
-24.09%-126.87M
-44.19%-37.51M
-8.20%-23.67M
-38.39%-33.4M
-6.86%-32.29M
6.87%-102.24M
9.88%-26.02M
15.30%-21.88M
9.57%-24.14M
-6.41%-30.21M
Net income continuous Operations
-24.09%-126.87M
-44.19%-37.51M
-8.20%-23.67M
-38.39%-33.4M
-6.86%-32.29M
6.87%-102.24M
9.88%-26.02M
15.30%-21.88M
9.57%-24.14M
-6.41%-30.21M
Minority interest income
Net income attributable to the parent company
-24.09%-126.87M
-44.19%-37.51M
-8.20%-23.67M
-38.39%-33.4M
-6.86%-32.29M
6.87%-102.24M
9.88%-26.02M
15.30%-21.88M
9.57%-24.14M
-6.41%-30.21M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-24.09%-126.87M
-44.19%-37.51M
-8.20%-23.67M
-38.39%-33.4M
-6.86%-32.29M
6.87%-102.24M
9.88%-26.02M
15.30%-21.88M
9.57%-24.14M
-6.41%-30.21M
Basic earnings per share
16.62%-2.96
-21.21%-0.8
19.12%-0.55
11.65%-0.91
25.38%-0.97
26.20%-3.55
45.90%-0.66
39.82%-0.68
12.71%-1.03
-4.00%-1.3
Diluted earnings per share
16.62%-2.96
-21.21%-0.8
19.12%-0.55
11.65%-0.91
25.38%-0.97
26.20%-3.55
45.90%-0.66
39.82%-0.68
12.71%-1.03
-4.00%-1.3
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 9.29%90.4M4.40%24.57M20.87%25.2M3.35%21.85M9.24%18.78M28.52%82.71M30.06%23.53M29.54%20.85M27.31%21.14M26.75%17.19M
Operating revenue 9.29%90.4M4.40%24.57M20.87%25.2M3.35%21.85M9.24%18.78M28.52%82.71M30.06%23.53M29.54%20.85M27.31%21.14M26.75%17.19M
Cost of revenue -5.13%8.88M8.09%2.47M3.63%2.45M-8.76%2.23M-23.71%1.73M22.30%9.36M1.02%2.29M17.18%2.37M32.34%2.44M48.52%2.27M
Gross profit 11.13%81.52M4.00%22.09M23.08%22.75M4.94%19.62M14.24%17.05M29.36%73.35M34.21%21.24M31.31%18.49M26.68%18.7M23.99%14.93M
Operating expense 28.38%178.3M38.77%49.75M25.98%40.3M33.39%45.46M15.74%42.79M2.32%138.89M-0.71%35.85M-0.56%31.99M1.81%34.08M8.75%36.97M
Selling and administrative expenses 29.89%121.15M41.98%34.86M33.03%28.94M33.62%30.06M11.54%27.3M12.60%93.27M13.48%24.55M14.07%21.76M7.97%22.49M14.90%24.47M
Research and development costs 25.28%57.15M31.78%14.89M11.00%11.36M32.96%15.4M23.97%15.49M-13.78%45.61M-21.93%11.3M-21.87%10.23M-8.35%11.58M-1.56%12.5M
Operating profit -47.68%-96.78M-89.32%-27.66M-29.96%-17.55M-67.98%-25.84M-16.76%-25.74M17.09%-65.54M27.97%-14.61M25.36%-13.5M17.81%-15.38M-0.40%-22.05M
Net non-operating interest income expense 70.02%-3.62M62.24%-1.08M101.21%36K47.71%-1.74M77.68%-649K-60.99%-12.07M-3.85%-2.86M-32.27%-2.98M-57.56%-3.33M-938.57%-2.91M
Non-operating interest income 237.03%8.9M287.33%2.81M230.18%2.76M295.86%1.72M178.76%1.8M181.56%2.64M54.80%726K89.34%835K239.84%435K32,150.00%645K
Non-operating interest expense -14.91%12.52M8.53%3.89M-28.68%2.72M-7.98%3.46M-31.13%2.45M74.39%14.72M11.26%3.59M41.61%3.82M67.98%3.76M1,159.93%3.55M
Other net income (expense) -14.13%-23.64M-30.51%-6.13M-12.30%-6.07M-7.69%-5.79M-11.53%-5.84M3.60%-20.71M8.77%-4.69M-13.09%-5.41M7.87%-5.37M10.14%-5.24M
Gain on sale of security -8.63%-23.41M-10.14%-6.06M-7.96%-5.92M-8.03%-5.77M-8.35%-5.66M0.03%-21.55M-8.34%-5.51M-13.70%-5.48M8.38%-5.34M10.33%-5.22M
Other non- operating income (expenses) -127.33%-229K-107.64%-62K-322.54%-158K53.33%-14K-1,120.00%-183K1,063.89%838K1,388.89%812K91.89%71K---30K-275.00%-15K
Income before tax -26.16%-124.04M-57.31%-34.86M-7.74%-23.58M-38.55%-33.37M-6.76%-32.23M8.98%-98.32M21.36%-22.16M12.87%-21.89M9.67%-24.08M-7.57%-30.19M
Income tax -27.76%2.83M-31.27%2.65M1,111.11%91K-29.63%38K157.14%54K123.36%3.92M459.36%3.85M-101.27%-9K68.75%54K-93.54%21K
Net income -24.09%-126.87M-44.19%-37.51M-8.20%-23.67M-38.39%-33.4M-6.86%-32.29M6.87%-102.24M9.88%-26.02M15.30%-21.88M9.57%-24.14M-6.41%-30.21M
Net income continuous Operations -24.09%-126.87M-44.19%-37.51M-8.20%-23.67M-38.39%-33.4M-6.86%-32.29M6.87%-102.24M9.88%-26.02M15.30%-21.88M9.57%-24.14M-6.41%-30.21M
Minority interest income
Net income attributable to the parent company -24.09%-126.87M-44.19%-37.51M-8.20%-23.67M-38.39%-33.4M-6.86%-32.29M6.87%-102.24M9.88%-26.02M15.30%-21.88M9.57%-24.14M-6.41%-30.21M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -24.09%-126.87M-44.19%-37.51M-8.20%-23.67M-38.39%-33.4M-6.86%-32.29M6.87%-102.24M9.88%-26.02M15.30%-21.88M9.57%-24.14M-6.41%-30.21M
Basic earnings per share 16.62%-2.96-21.21%-0.819.12%-0.5511.65%-0.9125.38%-0.9726.20%-3.5545.90%-0.6639.82%-0.6812.71%-1.03-4.00%-1.3
Diluted earnings per share 16.62%-2.96-21.21%-0.819.12%-0.5511.65%-0.9125.38%-0.9726.20%-3.5545.90%-0.6639.82%-0.6812.71%-1.03-4.00%-1.3
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Market Insights

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Cisco
CSCO
60.860
NVIDIA
NVDA
109.670
Broadcom
AVGO
169.120
4
Taiwan Semiconductor
TSM
165.250
5
ASML Holding
ASML
674.580
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Monetary Policy: Navigating the Fed's Rate Cut Cycle
Changing Fed policy is altering the market math for investors.